SHORT READ: According to DRG “physician-pharma rep engagement has declined significantly in the past year, with in-person interaction, traditionally pharma’s main commercial lever, accounting for most of the drop. Remote engagement is not yet picking up the slack. Interest in remote use has declined as the novelty has worn off, but remains substantial”.
Continue reading
SUMMARY: The CEOs of Abbvie, Bristol-Myers Squibb, Merck, Pfizer, Roche Pharmaceuticals, and Sanofi each contributed $15,600 to McConnell’s joint fundraising committee in the third quarter. Novo Nordisk Executive Vice President Doug Langa chipped in $10,000, Amgen CEO Robert Bradway gave $7,500, and Celgene CEO Mark Alles contributed $5,000. McConnell’s opposition to the bill comes after he had an exceptional quarter of fundraising from executives and PACs of pharmaceutical companies that could be forced to reduce the prices of their drugs under Medicare. Sigh..
Continue reading
KEY DATA: According to
THOUGHT: Digital “transformation” within pharma is taking a long time. The reasons for the delay are complex such as organizational culture and investments in infrastructure. It’s also hard to become digital when digital is a moving target.
Continue reading
SUMMARY: Los Angeles Times…”The most perplexing aspect of our current debate over healthcare and health coverage is the notion that Americans love their health insurance companies. The truth is that private health insurers have contributed nothing of value to the American healthcare system. Instead, they have raised costs and created an entitled class of administrators and executives who are fighting for their livelihoods, using customers’ premium dollars to do so.” Ouch
Continue reading
KEY SUMMARY: The idea that pharma “likes to keep people sick” is an excuse for poor lifestyle choices. The percentage of people who are overweight or obese soared from 22 percent in 1994 to 42 percent in 2016, nearly doubling. Obesity impacts where consumers spend their money. An individual with a body mass index (BMI) that’s considered “obese” spends 42 percent more on direct health care costs than adults who are a healthy weight.
Continue reading
